However, deal volume slipped somewhat during the same period, with a 16 percent decrease in transactions from the fourth quarter of 2010 and an 8 percent dip from the year-ago quarter.
Pharmaceutical M&A spending totaled $13.5 billion for the quarter, representing 24 percent of all healthcare M&A spending, and medical device M&A totaled $11.7 billion, or 21 percent of spending. Hospital M&A totaled $1.9 billion, or 4 percent of spending. M&A activity spending for physician medical groups was $14.6 million, less than 1 percent of spending.
By deal volume, long-term care ranked first among subsectors with 27 deals. Hospitals completed 23 deals, up 156 percent from 9 deals in the first quarter of 2010 but down 4 percent from the fourth quarter of 2010 (24 deals). Physician groups were involved in 12 deals, up 50 percent from a year ago.
Read the release on Irving Levin’s “The Health Care M&A Report“.
Read more coverage on healthcare M&A:
– Hospital M&A Continued to Grow in Second Half of 2010
– The Biggest Players in 2010 Healthcare M&A
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
